US EditionPublished • loading... • Updated
Prospera Biotech Licenses Its Vulvisens® Intimate Cream to Procare Health Laboratory to Integrate It Into Its International Line
Summary by RUVID
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The spin-off Prospera Biotech of the Science Park of the Miguel Hernández de Elche University (PCUMH), an licitan biotechnology company specializing in neurodermatology, has announced a strategic milestone in its history: to license its Vulvisens® intimate cream to the multinational Procare Health, which will incorporate it into its PalomaCare® line. This agreement opens the door to the internationalization of the product and consolidates neurod…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
